Karen Lewis - Feb 23, 2023 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Chief People Officer
Signature
/s/ David Watson, attorney-in-fact for Karen Lewis
Stock symbol
APLS
Transactions as of
Feb 23, 2023
Transactions value $
-$75,911
Form type
4
Date filed
2/27/2023, 03:32 PM
Previous filing
Feb 22, 2023
Next filing
Apr 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale -$75.9K -1.1K -2.6% $68.76 41.4K Feb 23, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale originated from established 10b5-1 trading plan.